| Primary |
| Hiv Infection |
77.0% |
| Hiv Test Positive |
7.0% |
| Hypertension |
3.9% |
| Prophylaxis |
1.6% |
| Pain |
1.2% |
| Asthma |
1.1% |
| Product Used For Unknown Indication |
1.1% |
| Depression |
1.1% |
| Anxiety |
0.9% |
| Diabetes Mellitus |
0.7% |
| Antifungal Prophylaxis |
0.5% |
| Gastrooesophageal Reflux Disease |
0.5% |
| Hypercholesterolaemia |
0.5% |
| Infection |
0.5% |
| Chronic Obstructive Pulmonary Disease |
0.4% |
| Herpes Virus Infection |
0.4% |
| Neuropathy Peripheral |
0.4% |
| Vitamin Supplementation |
0.4% |
| Insomnia |
0.4% |
| Thrombosis Prophylaxis |
0.4% |
|
| Myocardial Infarction |
17.8% |
| Death |
9.1% |
| Hodgkin's Disease |
8.8% |
| Acute Myocardial Infarction |
6.6% |
| Squamous Cell Carcinoma |
6.3% |
| Rectal Cancer |
4.8% |
| Chest Pain |
4.5% |
| Vomiting |
4.2% |
| Weight Decreased |
4.2% |
| Sepsis |
3.6% |
| Anal Cancer |
3.3% |
| Colon Cancer |
3.3% |
| Non-hodgkin's Lymphoma |
3.3% |
| Thrombocytopenia |
3.3% |
| Hepatic Failure |
3.0% |
| Pneumonia |
3.0% |
| Renal Failure |
3.0% |
| Septic Shock |
3.0% |
| Lymphoma |
2.4% |
| Cardiac Arrest |
2.1% |
|
| Secondary |
| Hiv Infection |
66.0% |
| Drug Use For Unknown Indication |
18.9% |
| Product Used For Unknown Indication |
5.1% |
| Hypertension |
1.6% |
| Hiv Test Positive |
1.5% |
| Antiretroviral Therapy |
1.1% |
| Anxiety |
0.6% |
| Prophylaxis |
0.6% |
| Antifungal Prophylaxis |
0.5% |
| Neuropathy Peripheral |
0.5% |
| Depression |
0.5% |
| Disseminated Cryptococcosis |
0.5% |
| Asthma |
0.4% |
| Herpes Virus Infection |
0.4% |
| Acquired Immunodeficiency Syndrome |
0.3% |
| Insomnia |
0.3% |
| Rhinitis Allergic |
0.3% |
| Drug Exposure During Pregnancy |
0.3% |
| Antiviral Treatment |
0.2% |
| Blood Pressure Increased |
0.2% |
|
| Weight Decreased |
15.4% |
| Neutropenia |
8.9% |
| Hodgkin's Disease |
7.1% |
| Thrombocytopenia |
7.1% |
| Viral Load Increased |
5.3% |
| Myocardial Infarction |
4.7% |
| Pancreatitis |
4.7% |
| Polyarthritis |
4.7% |
| Pulmonary Embolism |
4.1% |
| Sepsis |
4.1% |
| Death |
3.6% |
| Epistaxis |
3.6% |
| Hypokalaemia |
3.6% |
| Intestinal Perforation |
3.6% |
| Renal Failure Acute |
3.6% |
| Type 2 Diabetes Mellitus |
3.6% |
| Vomiting |
3.6% |
| Lipodystrophy Acquired |
3.0% |
| Pyrexia |
3.0% |
| Stevens-johnson Syndrome |
3.0% |
|
| Concomitant |
| Hiv Infection |
59.5% |
| Product Used For Unknown Indication |
13.8% |
| Drug Use For Unknown Indication |
5.4% |
| Antiretroviral Therapy |
3.4% |
| Hiv Test Positive |
3.1% |
| Hypertension |
3.0% |
| Acquired Immunodeficiency Syndrome |
2.4% |
| Prophylaxis |
1.4% |
| Premedication |
1.0% |
| Depression |
0.9% |
| Hiv Test |
0.9% |
| Migraine |
0.9% |
| Gout |
0.7% |
| Insomnia |
0.7% |
| Neuropathy Peripheral |
0.7% |
| Anxiety |
0.5% |
| Cerebral Toxoplasmosis |
0.5% |
| Hepatitis C |
0.5% |
| Anaemia |
0.4% |
| Eczema |
0.4% |
|
| Hepatic Steatosis |
12.9% |
| Vomiting |
10.6% |
| Rectal Cancer |
7.1% |
| Gamma-glutamyltransferase Increased |
5.9% |
| Lactic Acidosis |
5.9% |
| Viral Load Increased |
5.9% |
| Alanine Aminotransferase Increased |
4.7% |
| Blood Creatinine Increased |
4.7% |
| Cerebrovascular Accident |
4.7% |
| Renal Impairment |
4.7% |
| Type 2 Diabetes Mellitus |
4.7% |
| Abortion Spontaneous |
3.5% |
| Drug Interaction |
3.5% |
| Myocardial Infarction |
3.5% |
| Polyarthritis |
3.5% |
| Porphyria Non-acute |
3.5% |
| Renal Failure Acute |
3.5% |
| Adrenal Insufficiency |
2.4% |
| Cerebral Haemorrhage |
2.4% |
| Chest Pain |
2.4% |
|
| Interacting |
| Hiv Infection |
37.5% |
| Hiv Test Positive |
31.3% |
| Hypertension |
18.8% |
| Hiv Tropism Test |
12.5% |
|
| Adverse Event |
25.0% |
| Hospitalisation |
25.0% |
| Hypertensive Crisis |
25.0% |
| Rash Maculo-papular |
25.0% |
|
